secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-TECHNE Corp (TECH)
CIK:        0000842023
Form:       8-K
Filed at:   2024-08-07T23:59:59+00:00
Accession:  0001558370-24-011193
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Techne Q4 adjusted EPS $0.49 vs $0.55 YoY; revenue $306.1M (+2%)
--------------------------------------------------------------------

- Q4 organic revenue up 1% to $306.1M; FY2024 organic revenue up 1% to $1.2B.
- GAAP EPS $0.25 vs $0.47; adjusted EPS $0.49 vs $0.55.
- Diagnostics & Genomics segment grew 9% organically in Q4.
- FY2024 operating cash flow $299M, up 18% YoY.
- Board declared $0.08 quarterly dividend payable Aug 30, record Aug 19.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/842023/000155837024011193/0001558370-24-011193-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/842023/000155837024011193/tech-20240807x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-011193

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer